Stockreport

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF Palo Alto Investors LP initiated a new position in Compass Therapeutics (NASDAQ:CMPX) , buying 2,532,419 shares during the quarter for a position value of $13,599,090 a [Read more]